Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Drug discovery efforts based on DNA-encoded chemical libraries are inadvertently overlooking numerous potential drug ...

Using an AI-driven drug discovery process, the drug known as vorinostat was identified as a promising treatment for Rett ...

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are ...

Honolulu police arrested two men on Friday after reports of gunfire near a gold Honda. Officers recovered a firearm with a ...

A team of researchers from the MIT Sloan School of Management, the Sean M. Healey & AMG Center for ALS at Massachusetts ...

UB scientists Ram Samudrala, PhD, and Zackary M. Falls, PhD, talk about the new platform to make drug discovery faster and less expensive while also being safe and effective.

Bioinformatics is on the rise, forecasted to grow by about $16 billion from 2024 to 2029 given its value to managing mass ...

For the first time ever, the Inaugural Multi-Omics Based Drug Discovery & Development Summit 2025 has been positioned as the ...